Home

Neuland Laboratories Ltd PE Ratio

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

PE

70.1

Last updated on: Apr 21, 2025

Key Highlights

  • The P/E Ratio of Neuland Laboratories Ltd is 70.1 as of 21 Apr 9.00 AM .
  • The P/E Ratio of Neuland Laboratories Ltd changed from 22.5 on March 2020 to 27 on March 2024 . This represents a CAGR of 3.71% over 5 years.
  • The Latest Trading Price of Neuland Laboratories Ltd is ₹ 13116 as of 21 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Neuland Laboratories Ltd

No data available

Company Fundamentals for Neuland Laboratories Ltd

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

Share Price

₹ 13116.2

291.85 (2.28%)

stock direction

Last updated on: Apr 21, 2025

Market Price of Neuland Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Neuland Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Apr 202513116.2
17 Apr 202512824.35
16 Apr 202512742.1
15 Apr 202512655.3
11 Apr 202511705.4
09 Apr 202510943.35
08 Apr 202511201.8
07 Apr 202510949.25
04 Apr 202511448.9
03 Apr 202512037.35

SWOT Analysis Of Neuland Laboratories Ltd

Strength

5

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Neuland Laboratories Ltd

Asset Value vs Market Value of Neuland Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Neuland Laboratories Ltd16827
Sun Pharmaceutical Industries Ltd418468
Divis Laboratories Ltd156319
Cipla Ltd122071
Torrent Pharmaceuticals Ltd110120
Mankind Pharma Ltd106592

PE Ratio of Neuland Laboratories Ltd Explained

16827

Market cap

299

Earnings

70.1X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Neuland Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Neuland Laboratories Ltd

No data available

* All values are in %

About Neuland Laboratories Ltd

  • Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
  • The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
  • Neuland Drugs & Pharmaceuticals Pvt.
  • Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
  • NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.

Neuland Laboratories Ltd News Hub

Neuland Laboratories consolidated net profit rises 58.16% in the June 2024 quarter

Net profit of Neuland Laboratories rose 58.16% to Rs 97.87 crore in the quarter ended June 2024 as a

Read more

01 Aug 24

Neuland Laboratories to declare Quarterly Result

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 6 November 2024

Read more

18 Oct 24

Neuland Laboratories consolidated net profit declines 63.20% in the September 2024 quarter

Net profit of Neuland Laboratories declined 63.20% to Rs 32.84 crore in the quarter ended September

Read more

06 Nov 24

Neuland Laboratories Ltd leads losers in 'A' group

Hindustan Zinc Ltd, Five-Star Business Finance Ltd, Great Eastern Shipping Company Ltd and Triveni E

Read more

06 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Neuland Laboratories Ltd

What is the current PE Ratio of Neuland Laboratories Ltd?

The Current PE Ratio of Neuland Laboratories Ltd is 70.13 as on 21 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 21 Apr 2025.

What was the PE Ratio of Neuland Laboratories Ltd last year?

The PE Ratio of Neuland Laboratories Ltd was 14.2 last year, now the PE ratio is 70.13, showing a year-on-year growth of 393.9%.

What does the PE Ratio of Neuland Laboratories Ltd indicate about its stock?

The PE Ratio of Neuland Laboratories Ltd is 70.13. This ratio indicates that investors are willing to pay 70.13 times the earnings per share for each share of Neuland Laboratories Ltd.

What is the PE Ratio Growth of Neuland Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Neuland Laboratories Ltd grew by 393.9% whereas, the EPS ratio grew by 209.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions